---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-043277"
form_type: "8-K"
ticker: "KOD"
cik: "0001468748"
company_name: "Kodiak Sciences Inc."
filed_at: "2023-08-17T23:59:59+00:00"
generated_at: "2026-06-11T07:39:19.085173+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kodiak Sciences CMO and Chief Development Officer Dr. Jason Ehrlich resigns effective August 25, 2023

## Summary
- Resignation as Chief Medical Officer and Chief Development Officer effective August 25, 2023.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.
- No successor named in the filing.

## SEC filing metadata
- accession: 0000950170-23-043277
- form_type: 8-K
- ticker: KOD
- cik: 0001468748
- company_name: Kodiak Sciences Inc.
- filed_at: 2023-08-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468748/000095017023043277/0000950170-23-043277-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468748/000095017023043277/kod-20230816.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-043277
- JSON: https://secwatch.observer/filing/0000950170-23-043277.json
- Plain text: https://secwatch.observer/filing/0000950170-23-043277.txt

## Key facts
- Executive change
  Jason Ehrlich resigned as Chief Medical Officer and Chief Development Officer at Kodiak Sciences Inc..
  - Action: resigned
  - Role: Chief Medical Officer and Chief Development Officer
  source text: On August 16, 2023, Jason Ehrlich, M.D., Ph.D., informed the Company of his resignation as Chief Medical Officer and Chief Development Officer of the Company, effective August 25, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468748/000095017023043277/0000950170-23-043277-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.